Allspring Global Investments’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-95
| Closed | -$984 | – | 1969 |
|
|
2024
Q3 | $984 | Sell |
95
-2,572
| -96% | -$26.6K | ﹤0.01% | 2327 |
|
|
2024
Q2 | $34.6K | Buy |
+2,667
| New | +$34.6K | ﹤0.01% | 2019 |
|
|
2024
Q1 | – | Sell |
-504
| Closed | -$4.74K | – | 2323 |
|
|
2023
Q4 | $4.74K | Sell |
504
-107
| -18% | -$1.01K | ﹤0.01% | 2052 |
|
|
2023
Q3 | $6.82K | Sell |
611
-1,569
| -72% | -$17.5K | ﹤0.01% | 2649 |
|
|
2023
Q2 | $46.7K | Sell |
2,180
-352
| -14% | -$7.53K | ﹤0.01% | 2303 |
|
|
2023
Q1 | $102K | Sell |
2,532
-940
| -27% | -$38K | ﹤0.01% | 2037 |
|
|
2022
Q4 | $162K | Sell |
3,472
-2,065
| -37% | -$96.1K | ﹤0.01% | 1888 |
|
|
2022
Q3 | $287K | Buy |
5,537
+2,552
| +85% | +$132K | ﹤0.01% | 1712 |
|
|
2022
Q2 | $141K | Sell |
2,985
-14,846
| -83% | -$701K | ﹤0.01% | 1939 |
|
|
2022
Q1 | $1.27M | Buy |
17,831
+2,936
| +20% | +$209K | ﹤0.01% | 1747 |
|
|
2021
Q4 | $1.11M | Buy |
+14,895
| New | +$1.11M | ﹤0.01% | 1873 |
|